Condition
Insulin-requiring Type 2 Diabetes Mellitus
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Withdrawn1
Unknown1
Clinical Trials (2)
Showing 2 of 2 trials
NCT04189510Not ApplicableWithdrawn
Use of Closed Loop Insulin Delivery for Glucose Control in Patients With Insulin Dependent Diabetes Mellitus After Kidney Transplantation
NCT01500850Phase 4UnknownPrimary
Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use
Showing all 2 trials